NO302074B1 - Nye metylenbisfosfonsyrederivater - Google Patents

Nye metylenbisfosfonsyrederivater

Info

Publication number
NO302074B1
NO302074B1 NO932255A NO932255A NO302074B1 NO 302074 B1 NO302074 B1 NO 302074B1 NO 932255 A NO932255 A NO 932255A NO 932255 A NO932255 A NO 932255A NO 302074 B1 NO302074 B1 NO 302074B1
Authority
NO
Norway
Prior art keywords
bisphosphonic acid
opt
acid derivatives
alkyl
new methylene
Prior art date
Application number
NO932255A
Other languages
English (en)
Norwegian (no)
Other versions
NO932255L (no
NO932255D0 (no
Inventor
Esko Pohjala
Marjaana Heikkilae-Hoikka
Hannu Nikander
Hannu Hanhijaervi
Original Assignee
Leiras Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Leiras Oy filed Critical Leiras Oy
Publication of NO932255D0 publication Critical patent/NO932255D0/no
Publication of NO932255L publication Critical patent/NO932255L/no
Publication of NO302074B1 publication Critical patent/NO302074B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/40—Esters thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/40—Esters thereof
    • C07F9/4003—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4025—Esters of poly(thio)phosphonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/576—Six-membered rings
    • C07F9/58—Pyridine rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Paints Or Removers (AREA)
  • Detergent Compositions (AREA)
  • Luminescent Compositions (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Medicinal Preparation (AREA)
NO932255A 1990-12-20 1993-06-18 Nye metylenbisfosfonsyrederivater NO302074B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FI906295A FI89366C (fi) 1990-12-20 1990-12-20 Foerfarande foer framstaellning av nya farmakologiskt anvaendbara metylenbisfosfonsyraderivat
PCT/FI1991/000395 WO1992011269A1 (en) 1990-12-20 1991-12-18 Novel methylenebisphosphonic acid derivatives

Publications (3)

Publication Number Publication Date
NO932255D0 NO932255D0 (no) 1993-06-18
NO932255L NO932255L (no) 1993-08-20
NO302074B1 true NO302074B1 (no) 1998-01-19

Family

ID=8531620

Family Applications (1)

Application Number Title Priority Date Filing Date
NO932255A NO302074B1 (no) 1990-12-20 1993-06-18 Nye metylenbisfosfonsyrederivater

Country Status (25)

Country Link
US (1) US5393748A (ko)
EP (1) EP0563107B1 (ko)
JP (1) JP3224817B2 (ko)
KR (1) KR100220157B1 (ko)
CN (1) CN1030253C (ko)
AT (1) ATE192452T1 (ko)
AU (1) AU664541B2 (ko)
CA (1) CA2098735C (ko)
CZ (1) CZ288084B6 (ko)
DE (1) DE69132164T2 (ko)
DK (1) DK0563107T3 (ko)
EE (1) EE02949B1 (ko)
ES (1) ES2147726T3 (ko)
FI (1) FI89366C (ko)
HU (1) HUT64549A (ko)
IE (1) IE914389A1 (ko)
IL (1) IL100337A (ko)
NO (1) NO302074B1 (ko)
NZ (1) NZ241040A (ko)
PL (1) PL169796B1 (ko)
RU (1) RU2086556C1 (ko)
SK (1) SK279601B6 (ko)
TW (1) TW201752B (ko)
WO (1) WO1992011269A1 (ko)
ZA (1) ZA9110008B (ko)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI89365C (fi) * 1990-12-20 1993-09-27 Leiras Oy Foerfarande foer framstaellning av nya farmakologiskt anvaendbara metylenbisfosfonsyraderivat
US5157027A (en) * 1991-05-13 1992-10-20 E. R. Squibb & Sons, Inc. Bisphosphonate squalene synthetase inhibitors and method
CA2122479C (en) * 1991-11-22 1998-08-25 Richard John Dansereau Risedronate delayed-release compositions
US6406714B1 (en) 1992-12-02 2002-06-18 Merck & Co., Inc. Dry mix formulation for bisphosphonic acids
US6444656B1 (en) 1992-12-23 2002-09-03 Biochem Pharma, Inc. Antiviral phosphonate nucleotides
GB9226879D0 (en) * 1992-12-23 1993-02-17 Iaf Biochem Int Anti-viral compounds
US6005107A (en) * 1992-12-23 1999-12-21 Biochem Pharma, Inc. Antiviral compounds
TW390813B (en) * 1994-04-29 2000-05-21 Merck & Co Inc Wet granulation formulation for bisphosphonic acids
US20010007863A1 (en) 1998-06-18 2001-07-12 Merck & Co., Inc. Wet granulation formulation for bisphosphonic acids
DE4435496A1 (de) * 1994-10-04 1996-04-11 Hoechst Ag Imidobisphosphorsäuren, Verfahren zu ihrer Herstellung und Verwendung derselben
FI104901B (fi) * 1997-10-20 2000-04-28 Leiras Oy Uudet metyleenibisfosfonihappojohdannaiset
CN1215076C (zh) 1998-09-09 2005-08-17 症变治疗公司 新的果糖1,6－二磷酸酶的杂芳族抑制剂
SE9903345D0 (sv) 1999-09-17 1999-09-17 Astra Pharma Prod Novel process
US7563774B2 (en) 2000-06-29 2009-07-21 Metabasis Therapeutics, Inc. Combination of FBPase inhibitors and antidiabetic agents useful for the treatment of diabetes
EP1328277B1 (en) * 2000-10-27 2007-02-14 Schering Aktiengesellschaft Bisphosphonic compounds for strengthening of cortical bone
US20030036537A1 (en) * 2001-07-16 2003-02-20 Marc Lecouvey Bisphosphonate derivatives, their preparations and uses
ATE455121T1 (de) * 2001-07-16 2010-01-15 Univ Paris 13 Herstellungsverfahren von derivate von bisphosphonaten
FR2837490B1 (fr) * 2002-03-21 2009-04-17 Univ Paris 13 Nouveaux derives de bisphosphonates, leurs preparations et utilisations
AU2003211022A1 (en) * 2002-02-19 2003-09-09 Ilex Products, Inc. Aminodiphosphonate apolipoprotein e modulators
US7862552B2 (en) 2005-05-09 2011-01-04 Boston Scientific Scimed, Inc. Medical devices for treating urological and uterine conditions
WO2010003704A2 (en) * 2008-07-11 2010-01-14 Synthon B.V. Process for making 1-hydroxyalkylidene-1,1-biphosphonic acids
JP5850842B2 (ja) * 2009-10-26 2016-02-03 ワーナー・チルコット・カンパニー・エルエルシー 骨代謝疾患を治療するためのビスホスホネート化合物
TWI730039B (zh) 2016-01-29 2021-06-11 日商富士藥品股份有限公司 新穎雙膦酸化合物
CN108218918A (zh) * 2018-03-01 2018-06-29 四川大学 芳基偕二磷酸衍生物制备方法和用途

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3303139A (en) * 1962-01-27 1967-02-07 Henkel & Cie Gmbh Aminophosphonic acids and their derivatives as complex formers for metal ions
DE1617118C3 (de) * 1966-08-26 1975-04-03 Henkel & Cie Gmbh, 4000 Duesseldorf Verfahren zur Reinigung von etikettierten starren Gegenständen
US3957858A (en) * 1970-04-13 1976-05-18 Monsanto Company Substituted ethane diphosphonic acids and salts and esters thereof
US3962318A (en) * 1970-04-13 1976-06-08 Monsanto Company Substituted ethane diphosphonic acids and salts and esters thereof
US4447256A (en) * 1977-07-20 1984-05-08 Nissan Chemical Industries, Ltd. N-(Unsubstituted or substituted pyridyl)aminomethylene-diphosphonic acids, herbicidal compositions containing same, their use for herbicides, and process for preparing same
IL77243A (en) * 1984-12-21 1996-11-14 Procter & Gamble Pharmaceutical compositions containing geminal diphosphonic acid compounds and certain such novel compounds
GB8530603D0 (en) * 1985-12-12 1986-01-22 Leo Pharm Prod Ltd Chemical compounds
US4973576A (en) * 1987-03-10 1990-11-27 Yamanouchi Pharmaceutical Co., Ltd. Bisphophonic acid derivatives and pharmaceutical compositions containing the same
EP0356866A3 (en) * 1988-08-29 1991-03-27 E.R. SQUIBB & SONS, INC. Phosphorus-containing squalene synthetase inhibitors and method

Also Published As

Publication number Publication date
WO1992011269A1 (en) 1992-07-09
AU9068291A (en) 1992-07-22
CZ288084B6 (cs) 2001-04-11
PL169796B1 (pl) 1996-08-30
FI906295A (fi) 1992-06-21
CA2098735C (en) 2002-03-05
ATE192452T1 (de) 2000-05-15
EE02949B1 (et) 1996-12-16
AU664541B2 (en) 1995-11-23
JP3224817B2 (ja) 2001-11-05
SK279601B6 (sk) 1999-01-11
RU2086556C1 (ru) 1997-08-10
NO932255L (no) 1993-08-20
NO932255D0 (no) 1993-06-18
CZ121793A3 (en) 1994-10-19
SK63493A3 (en) 1994-09-07
TW201752B (ko) 1993-03-11
KR930703335A (ko) 1993-11-29
NZ241040A (en) 1994-07-26
IE914389A1 (en) 1992-07-01
DK0563107T3 (da) 2000-09-25
FI906295A0 (fi) 1990-12-20
ES2147726T3 (es) 2000-10-01
DE69132164T2 (de) 2001-01-11
EP0563107B1 (en) 2000-05-03
IL100337A (en) 2000-12-06
CA2098735A1 (en) 1992-06-21
FI89366B (fi) 1993-06-15
KR100220157B1 (ko) 1999-10-01
CN1030253C (zh) 1995-11-15
JPH06504769A (ja) 1994-06-02
EP0563107A1 (en) 1993-10-06
US5393748A (en) 1995-02-28
HUT64549A (en) 1994-01-28
IL100337A0 (en) 1992-09-06
DE69132164D1 (de) 2000-06-08
HU9301781D0 (en) 1993-09-28
FI89366C (fi) 1993-09-27
ZA9110008B (en) 1992-09-30
CN1062534A (zh) 1992-07-08

Similar Documents

Publication Publication Date Title
NO302074B1 (no) Nye metylenbisfosfonsyrederivater
DK0563096T3 (da) Nye methylenbisphosphonsyrederivater
NL980001I1 (nl) Therapeutische heterocyclische verbindingen.
NO180540B (no) Analogifremgangsmåte for fremstilling av terapeutisk aktiv cyklisk amidderivat
KR910000765A (ko) 포스핀산 유도체
EE9800144A (et) Indool-2,3-dioon-3-oksiimi derivaadid, nende valmistamismeetod, kasutamine ja farmatseutiline kompositsioon
DK0655461T3 (da) Cykliske aminosyrederivater med ACE- og NEP-inhiberende aktivitet
FI883603A0 (fi) Menetelmä terapeuttisesti käyttökelpoisten 1,4-dihydropyridiinijohdannaisten valmistamiseksi
ES2109988T3 (es) Derivados cefalosporinicos.
FI870151A0 (fi) Dihydropyridinlaktoler, foerfarande foer deras framstaellning och deras anvaendning i laekemedel.
TH7294B (th) คาร์บอกซิแอลคีนามิโดเซฟาโลสพอริน
DE2963724D1 (en) Clavulanic acid derivatives, their preparation and pharmaceutical compositions containing them

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees